NCT00416702View on ClinicalTrials.gov

Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

March 31, 2008

Conditions
Hepatic Insufficiency
Interventions
DRUG

QAB149

Trial Locations (1)

07936-1080

Novartis Investigative Site, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY